MedPath

Vaproizing

HEB 397.002/397AA rev 2-AB Medicated Vaporizing Steam Liquid

Approved
Approval ID

577fda09-588a-4c2e-ada5-eeda32d1aabe

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 1, 2025

Manufacturers
FDA

H E B

DUNS: 007924756

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Camphor

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code37808-397
Application NumberM012
Product Classification
M
Marketing Category
C200263
G
Generic Name
Camphor
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateMay 1, 2025
FDA Product Classification

INGREDIENTS (9)

ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
EUCALYPTUS OILInactive
Code: 2R04ONI662
Classification: IACT
DIMETHICONEInactive
Code: 92RU3N3Y1O
Classification: IACT
LAURETH-7Inactive
Code: Z95S6G8201
Classification: IACT
NUTMEG OILInactive
Code: Z1CLM48948
Classification: IACT
CEDAR LEAF OILInactive
Code: BJ169U4NLG
Classification: IACT
CAMPHOR (NATURAL)Active
Quantity: 62 mg in 1 mL
Code: N20HL7Q941
Classification: ACTIB
MENTHOLInactive
Code: L7T10EIP3A
Classification: IACT
POLOXAMER 124Inactive
Code: 1S66E28KXA
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Vaproizing - FDA Drug Approval Details